Quotient Limited Stock News

Engaged Capital recently sent a letter to Quotient Technologys board, calling out its underperformance versus its peers.

Quotient Limited (NASDAQ:QTNT)s traded shares stood at 3.14 million during the last session, with the companys beta value hitting 2.35. At the close of trading, the stocks price was $2.25, to imply an increase of 5.63% or $0.12 in intraday trading. The QTNT shares 52-week high remains $7.59, putting it -237.33% down since that peak Quotient Limited (NASDAQ: QTNT) Is Currently -237.33 Percent Below Its 52-Week High, But It Still Offers Strong Upside Potential. Read More »

In the last trading session, 3.17 million Quotient Limited (NASDAQ:QTNT) shares changed hands as the companys beta touched 2.35. With the companys per share price at $2.13 changed hands at -$0.23 or -9.75% during last session, the market valuation stood at $241.39M. QTNTs last price was a discount, traded about -256.34% off its 52-week high Quotient Limited (NASDAQ: QTNT) Stock Could Reward Investors With A -557.28% Loss Read More »

Quotient (NASDAQ:QTNT) had its price objective lowered by The Goldman Sachs Group from $4.00 to $3.50 in a report published on Friday, Analyst Ratings Network reports. The brokerage currently has a neutral rating on the stock. Separately, Zacks Investment Research downgraded Quotient from a buy rating to a hold rating in a research note on []

Quotient (NASDAQ:QTNT) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a note issued to investors on Saturday, Zacks.com reports. The firm presently has a $2.75 target price on the stock. Zacks Investment Researchs price objective indicates a potential upside of 29.11% from the stocks current price. According to []

Quotient (NASDAQ:QTNT) had its target price cut by The Goldman Sachs Group from $4.00 to $3.50 in a report released on Friday, Price Targets.com reports. They currently have a neutral rating on the stock. Separately, Zacks Investment Research downgraded shares of Quotient from a buy rating to a hold rating in a research report on []

Quotient Limited (NASDAQ:QTNT) has a beta value of 2.33 and has seen 2.56 million shares traded in the last trading session. The company, currently valued at $221.14M, closed the last trade at $2.12 per share which meant it gained $0.04 on the day or 1.92% during that session. The QTNT stock price is -258.02% off Quotient Limited (QTNT) Has A Promising Outlook For 2021 Read More »

Related Stocks: LHX , AON , CVS , LH , NVDA , BABA , GE , DFAS , NOV , GME , PUK , NTLA , CMI , WU , HPQ , WHR , THO , MRK , PROS , QTNT , CORE , FPI , WD , SCI ,

JERSEY, Channel Islands, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Mr. Esteban Uriarte as the Companys Chief Manufacturing Operations Officer (CMOO). Mr. Uriarte will assume the responsibilities of CMOO on February 1 st , 2022.

Nuveen Asset Management LLC grew its position in shares of Quotient Limited (NASDAQ:QTNT) by 20.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 351,192 shares of the companys stock after purchasing an additional 58,717 shares during the quarter. Nuveen []

Gofen & Glossberg LLC IL acquired a new position in shares of Quotient Limited (NASDAQ:QTNT) during the third quarter, Holdings Channel.com reports. The institutional investor acquired 25,000 shares of the company’s stock, valued at approximately $59,000. Other hedge funds have also recently modified their holdings of the company. Nisa Investment Advisors LLC bought a new […]

Quotient (NASDAQ:QTNT) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in []

Investors need to pay close attention to Quotient Limited (QTNT) stock based on the movements in the options market lately.

Quotient Limited (NASDAQ:QTNT) Equities research analysts at Jefferies Financial Group lifted their Q3 2022 EPS estimates for Quotient in a research report issued to clients and investors on Tuesday, November 16th. Jefferies Financial Group analyst B. Couillard now expects that the company will earn ($0.25) per share for the quarter, up from their previous []

JERSEY, Channel Islands, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Ali Kiboro, who has been appointed as the Chief Financial Officer of the Company effective November 1, 2021.